BIO FY 2011 Earnings Report — Bio-Rad Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

Bio-Rad Laboratories, Inc.BIO

FY 2011 Earnings

Reported February 29, 2012

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2011	Prior Q	FY 2010	QoQ Change	YoY Change
Revenue	$2.1B	—	—	—	—
Op. Income	$295M	—	—	—	—
Gross Margin	56.8%	—	—	—	—
Net Margin	8.6%	—	—	—	—
EPS (Diluted)	$6.29	—	—	—	—
Free Cash Flow	$159M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$2.1B
Cost of Revenue	$896M
GROSS PROFIT	$1.2B
R&D Expenses	$186M
Selling & Marketing	$0
General & Administrative	$696M
SG&A Expenses	$696M
Other Expenses	$0
Operating Expenses	$883M
Cost & Expenses	$1.8B
OPERATING INCOME	$295M
Interest Income	$8M
Interest Expense	$53M
Other Income/Expenses	-$59M
INCOME BEFORE TAX	$236M
Income Tax Expense	$58M
Net Income from Continuing Ops	$178M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$178M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$178M
D&A	$121M
EBIT	$299M
EBITDA	$410M
EPS	$6
EPS Diluted	$6

Income Statement

Item	Amount
REVENUE	$2.1B
Cost of Revenue	$896M
GROSS PROFIT	$1.2B
R&D Expenses	$186M
Selling & Marketing	$0
General & Administrative	$696M
SG&A Expenses	$696M
Other Expenses	$0
Operating Expenses	$883M
Cost & Expenses	$1.8B
OPERATING INCOME	$295M
Interest Income	$8M
Interest Expense	$53M
Other Income/Expenses	-$59M
INCOME BEFORE TAX	$236M
Income Tax Expense	$58M
Net Income from Continuing Ops	$178M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$178M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$178M
D&A	$121M
EBIT	$299M
EBITDA	$410M
EPS	$6
EPS Diluted	$6

Cash Flow Statement

Item	Amount
Net Income	$179M
Depreciation & Amortization	$121M
Stock-Based Compensation	$11M
Deferred Income Tax	$0
Other Non-Cash Items	-$1M
Change in Working Capital	-$46M
OPERATING CASH FLOW	$263M
Capital Expenditure	-$103M
Acquisitions (Net)	-$159M
Purchases of Investments	-$509M
Sales/Maturities of Investments	$385M
Other Investing Activities	$234.0K
NET CASH FROM INVESTING	-$386M
Net Debt Issuance	-$231M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$3M
NET CASH FROM FINANCING	-$214M
FREE CASH FLOW	$159M
Net Change in Cash	-$332M

Balance Sheet

Item	Amount
Cash & Equivalents	$574M
Short-Term Investments	$239M
Net Receivables	$399M
Inventory	$434M
Other Current Assets	$54M
TOTAL CURRENT ASSETS	$1.8B
PP&E (Net)	$350M
Goodwill	$469M
Intangible Assets	$260M
Long-Term Investments	$0
Tax Assets	$11M
Other Non-Current Assets	$210M
TOTAL NON-CURRENT ASSETS	$1.3B
TOTAL ASSETS	$3.1B
Account Payables	$129M
Short-Term Debt	$814.0K
Deferred Revenue	$24M
Other Current Liabilities	$115M
TOTAL CURRENT LIABILITIES	$459M
Long-Term Debt	$732M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$86M
Other Non-Current Liabilities	$76M
TOTAL NON-CURRENT LIABILITIES	$893M
TOTAL LIABILITIES	$1.4B
Common Stock	$3.0K
Additional Paid-In Capital	$185M
Retained Earnings	$1.4B
Treasury Stock	$0
Accum. Other Comp. Income	$199M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.7B
Minority Interest	$445.0K
TOTAL EQUITY	$1.7B
TOTAL LIABILITIES & EQUITY	$3.1B
Total Debt	$733M
Net Debt	$158M